187 related articles for article (PubMed ID: 1688510)
21. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
Carney DN; Cuttitta F; Moody TW; Minna JD
Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
[TBL] [Abstract][Full Text] [Related]
22. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
Sethi T; Langdon S; Smyth J; Rozengurt E
Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway.
Seckl MJ; Seufferlein T; Rozengurt E
Cancer Res; 1994 Dec; 54(23):6143-7. PubMed ID: 7525056
[TBL] [Abstract][Full Text] [Related]
24. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.
Seckl MJ; Higgins T; Rozengurt E
J Biol Chem; 1996 Nov; 271(46):29453-60. PubMed ID: 8910612
[TBL] [Abstract][Full Text] [Related]
25. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
26. [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.
Seckl MJ; Higgins T; Widmer F; Rozengurt E
Cancer Res; 1997 Jan; 57(1):51-4. PubMed ID: 8988040
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity.
Bunn PA; Chan D; Dienhart DG; Tolley R; Tagawa M; Jewett PB
Cancer Res; 1992 Jan; 52(1):24-31. PubMed ID: 1309227
[TBL] [Abstract][Full Text] [Related]
28. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
MacKinnon AC; Armstrong RA; Waters CM; Cummings J; Smyth JF; Haslett C; Sethi T
Br J Cancer; 1999 Jun; 80(7):1026-34. PubMed ID: 10362111
[TBL] [Abstract][Full Text] [Related]
29. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides.
Gudermann T; Roelle S
Endocr Relat Cancer; 2006 Dec; 13(4):1069-84. PubMed ID: 17158754
[TBL] [Abstract][Full Text] [Related]
30. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
31. [The role of gastrin releasing peptide as a lung growth factor].
Thomas F; Morin A; Moreau JP; Calvo F; Poupon MF
Rev Mal Respir; 1992; 9(2):125-37. PubMed ID: 1565825
[TBL] [Abstract][Full Text] [Related]
32. Effects of bombesin and gastrin-releasing peptide on human bronchial epithelial cells from a series of donors: individual variation and modulation by bombesin analogs.
Siegfried JM; Guentert PJ; Gaither AL
Anat Rec; 1993 May; 236(1):241-7. PubMed ID: 8507011
[TBL] [Abstract][Full Text] [Related]
33. Activation of inositol phospholipid signaling and Ca2+ efflux in human breast cancer cells by bombesin.
Patel KV; Schrey MP
Cancer Res; 1990 Jan; 50(2):235-9. PubMed ID: 2153048
[TBL] [Abstract][Full Text] [Related]
34. Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P.
Mitchell FM; Heasley LE; Qian NX; Zamarripa J; Johnson GL
J Biol Chem; 1995 Apr; 270(15):8623-8. PubMed ID: 7536738
[TBL] [Abstract][Full Text] [Related]
35. Substance P-related antagonists inhibit vasopressin and bombesin but not 5'-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells.
Seckl MJ; Newman RH; Freemont PS; Rozengurt E
J Cell Physiol; 1995 Apr; 163(1):87-95. PubMed ID: 7534771
[TBL] [Abstract][Full Text] [Related]
36. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
37. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines.
Yano T; Pinski J; Groot K; Schally AV
Cancer Res; 1992 Aug; 52(16):4545-7. PubMed ID: 1643647
[TBL] [Abstract][Full Text] [Related]
38. Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cells.
Moody TW; Murphy A; Mahmoud S; Fiskum G
Biochem Biophys Res Commun; 1987 Aug; 147(1):189-95. PubMed ID: 2443131
[TBL] [Abstract][Full Text] [Related]
39. A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells.
Zachary I; Rozengurt E
Biochem Biophys Res Commun; 1986 May; 137(1):135-41. PubMed ID: 2424443
[TBL] [Abstract][Full Text] [Related]
40. The release of bombesin-like peptides from small cell lung cancer cells.
Moody TW; Korman LY
Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
